Caxton Associates LP Taro Pharmaceutical Industries LTD Transaction History

Caxton Associates LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$54.41 - $68.2 $482,671 - $605,002	-8,871 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$59.35 - $88.73 $218,467 - $326,615	-3,681 Reduced 29.33%	8,871 $543,000
Q4 2019 Feb 14, 2020	BUY	$74.18 - $97.92 $273,501 - $361,031	3,687 Added 41.59%	12,552 $1.1 Million
Q3 2019 Nov 14, 2019	BUY	$75.36 - $86.57 $464,895 - $534,050	6,169 Added 228.82%	8,865 $669,000
Q1 2019 May 15, 2019	BUY	$85.97 - $108.09 $231,775 - $291,410	2,696 New	2,696 $291,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.